Differentiation of multiple system atrophy subtypes by gray matter atrophy.


Journal

Journal of neuroimaging : official journal of the American Society of Neuroimaging
ISSN: 1552-6569
Titre abrégé: J Neuroimaging
Pays: United States
ID NLM: 9102705

Informations de publication

Date de publication:
01 2022
Historique:
revised: 30 07 2021
received: 15 06 2021
accepted: 18 08 2021
pubmed: 11 9 2021
medline: 19 3 2022
entrez: 10 9 2021
Statut: ppublish

Résumé

Multiple system atrophy(MSA) is a rare adult-onset synucleinopathy that can be divided in two subtypes depending on whether the prevalence of its symptoms is more parkinsonian or cerebellar (MSA-P and MSA-C, respectively). The aim of this work is to investigate the structural MRI changes able to discriminate MSA phenotypes. The sample includes 31 MSA patients (15 MSA-C and 16 MSA-P) and 39 healthy controls. Participants underwent a comprehensive motor and neuropsychological battery. MRI data were acquired with a 3T scanner (MAGNETOM Trio, Siemens, Germany). FreeSurfer was used to obtain volumetric and cortical thickness measures. A Support Vector Machine (SVM) algorithm was used to assess the classification between patients' group using cortical and subcortical structural data. After correction for multiple comparisons, MSA-C patients had greater atrophy than MSA-P in the left cerebellum, whereas MSA-P showed reduced volume bilaterally in the pallidum and putamen. Using deep gray matter volume ratios and mean cortical thickness as features, the SVM algorithm provided a consistent classification between MSA-C and MSA-P patients (balanced accuracy 74.2%, specificity 75.0%, and sensitivity 73.3%). The cerebellum, putamen, thalamus, ventral diencephalon, pallidum, and caudate were the most contributing features to the classification decision (z > 3.28; p < .05 [false discovery rate]). MSA-C and MSA-P with similar disease severity and duration have a differential distribution of gray matter atrophy. Although cerebellar atrophy is a clear differentiator between groups, thalamic and basal ganglia structures are also relevant contributors to distinguishing MSA subtypes.

Sections du résumé

BACKGROUND AND PURPOSE
Multiple system atrophy(MSA) is a rare adult-onset synucleinopathy that can be divided in two subtypes depending on whether the prevalence of its symptoms is more parkinsonian or cerebellar (MSA-P and MSA-C, respectively). The aim of this work is to investigate the structural MRI changes able to discriminate MSA phenotypes.
METHODS
The sample includes 31 MSA patients (15 MSA-C and 16 MSA-P) and 39 healthy controls. Participants underwent a comprehensive motor and neuropsychological battery. MRI data were acquired with a 3T scanner (MAGNETOM Trio, Siemens, Germany). FreeSurfer was used to obtain volumetric and cortical thickness measures. A Support Vector Machine (SVM) algorithm was used to assess the classification between patients' group using cortical and subcortical structural data.
RESULTS
After correction for multiple comparisons, MSA-C patients had greater atrophy than MSA-P in the left cerebellum, whereas MSA-P showed reduced volume bilaterally in the pallidum and putamen. Using deep gray matter volume ratios and mean cortical thickness as features, the SVM algorithm provided a consistent classification between MSA-C and MSA-P patients (balanced accuracy 74.2%, specificity 75.0%, and sensitivity 73.3%). The cerebellum, putamen, thalamus, ventral diencephalon, pallidum, and caudate were the most contributing features to the classification decision (z > 3.28; p < .05 [false discovery rate]).
CONCLUSIONS
MSA-C and MSA-P with similar disease severity and duration have a differential distribution of gray matter atrophy. Although cerebellar atrophy is a clear differentiator between groups, thalamic and basal ganglia structures are also relevant contributors to distinguishing MSA subtypes.

Identifiants

pubmed: 34506665
doi: 10.1111/jon.12927
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

80-89

Informations de copyright

© 2021 The Authors. Journal of Neuroimaging published by Wiley Periodicals LLC on behalf of American Society of Neuroimaging.

Références

Fanciulli A, Wenning GK. Multiple-system atrophy. N Engl J Med 2015;372:249-63.
Lin DJ, Hermann KL, Schmahmann JD. Multiple system atrophy of the cerebellar type: clinical state of the art. Mov Disord 2014;29:294-304.
Lantos PL. The definition of multiple system atrophy. J Neuropathol Exp Neurol 1998;57:1099-111.
Wenning GK, Quinn NP. Parkinsonism. Multiple system atrophy. Baillieres Clin Neurol 1997;6:187-204.
Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670-6.
Brenneis C, Seppi K, Schocke MF, et al. Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy. Mov Disord 2003;18:1132-8.
Caso F, Canu E, Lukic MJ, et al. Cognitive impairment and structural brain damage in multiple system atrophy-parkinsonian variant. J Neurol 2020;267:87-94.
Chang CC, Chang YY, Chang WN, et al. Cognitive deficits in multiple system atrophy correlate with frontal atrophy and disease duration. Eur J Neurol 2009;16:1144-50.
Huppertz H-J, Möller L, Südmeyer M, et al. Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification. Mov Disord 2016;31:1506-17.
Paviour DC, Price SL, Jahanshahi M, et al. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. Mov Disord 2006;21:989-96.
Planetta PJ, Kurani AS, Shukla P, et al. Distinct functional and macrostructural brain changes in Parkinson's disease and multiple system atrophy. Hum Brain Mapp 2015;36:1165-79
Kim JS, Yang J, Lee D-K, et al. Cognitive impairment and its structural correlates in the Parkinsonian subtype of multiple system atrophy. Neurodegener Dis 2015;15:294-300.
Tir M, Delmaire C, le Thuc V, et al. Motor-related circuit dysfunction in MSA-P: usefulness of combined whole-brain imaging analysis. Mov Disord 2009;24:863-70.
Yang H, Wang N, Luo X, et al. Cerebellar atrophy and its contribution to motor and cognitive performance in multiple system atrophy. NeuroImage Clin 2019;23:101891.
Dash SK, Stezin A, Takalkar T, et al. Abnormalities of white and grey matter in early multiple system atrophy: comparison of parkinsonian and cerebellar variants. Eur Radiol 2019;29:716-24
Lee MJ, Shin J-H, Seoung J-K, et al. Cognitive impairments associated with morphological changes in cortical and subcortical structures in multiple system atrophy of the cerebellar type. Eur J Neurol 2016;23:92-100.
Zhang H, Ji S, Ren S, et al. Cerebellar atrophy in multiple system atrophy (cerebellar type) and its implication for network connectivity. Cerebellum 2020;19:636-44.
Kim JS, Youn J, Yang J-J, et al. Topographic distribution of cortical thinning in subtypes of multiple system atrophy. Parkinsonism Relat Disord 2013;19:970-4.
Barbagallo G, Sierra-Peña M, Nemmi F, et al. Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease. Mov Disord 2016;31:325-34.
Krismer F, Seppi K, Göbel G, et al. Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis. Mov Disord 2019;34:1041-8.
Lee EA, Cho HI, Kim SS, et al. Comparison of magnetic resonance imaging in subtypes of multiple system atrophy. Parkinsonism Relat Disord 2004;10:363-8.
Schulz JB, Skalej M, Wedekind D, et al. Magnetic resonance imaging-based bolumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol 1999;45:65-74.
Abos A, Baggio HC, Segura B, et al. Differentiation of multiple system atrophy from Parkinson's disease by structural connectivity derived from probabilistic tractography. Sci Rep 2019;9:16488.
Péran P, Barbagallo G, Nemmi F, et al. MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophy. Mov Disord 201833:600-8
Scherfler C, Göbel G, Müller C, et al. Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonism. Neurology 2016;86:1242-9.
Lezak MD. Neuropsychological Assessment. Oxford: Oxford University Press; 2012.
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-14.
Beck A, Steer RBG. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.
Starkstein SE, Mayberg HS, Preziosi TJ, et al. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992;4:134-9.
Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 1998;17:87-97.
Ségonne F, Pacheco J, Fischl B. Geometrically accurate topology-correction of cortical surfaces using nonseparating loops. IEEE Trans Med Imaging 2007;26:518-29
Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 2000;97:11050-5.
Gómez-Verdejo V, Parrado-Hernández E, Tohka J. Sign-consistency based variable importance for machine learning in brain imaging. Neuroinformatics 2019;17:593-609.
Koutsouleris N, Dwyer DB, Degenhardt F, et al. Multimodal machine learning workflows for prediction of psychosis in patients with clinical high-risk syndromes and recent-onset depression. JAMA Psychiatry 2021;78:195.
Chelban V, Bocchetta M, Hassanein S, et al. An update on advances in magnetic resonance imaging of multiple system atrophy. J Neurol 2019;266:1036-45.
Kawai Y, Suenaga M, Takeda A, et al. Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P. Neurology 2008;70:1390-6.

Auteurs

Anna Campabadal (A)

Medical Psychology Unit, Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.
Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Alexandra Abos (A)

Medical Psychology Unit, Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.

Barbara Segura (B)

Medical Psychology Unit, Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.
Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.

Gemma Monte-Rubio (G)

Medical Psychology Unit, Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.

Alexandra Perez-Soriano (A)

Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
Movement Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Barcelona, Spain.
Institute of Neuroscience, University of Barcelona, Barcelona, Spain.

Darly Milena Giraldo (DM)

Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
Movement Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Barcelona, Spain.
Institute of Neuroscience, University of Barcelona, Barcelona, Spain.

Esteban Muñoz (E)

Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
Movement Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Barcelona, Spain.
Institute of Neuroscience, University of Barcelona, Barcelona, Spain.

Yaroslau Compta (Y)

Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
Movement Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Barcelona, Spain.
Institute of Neuroscience, University of Barcelona, Barcelona, Spain.

Carme Junque (C)

Medical Psychology Unit, Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.
Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.

Maria Jose Marti (MJ)

Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
Movement Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Barcelona, Spain.
Institute of Neuroscience, University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH